BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim HY, Hanrahan CF, Martinson N, Golub JE, Dowdy DW. Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa. Int J Tuberc Lung Dis 2018;22:1435-42. [PMID: 30606315 DOI: 10.5588/ijtld.18.0370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Lancet Glob Health 2020;8:e1223-33. [PMID: 32827484 DOI: 10.1016/S2214-109X(20)30227-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uppal A, Rahman S, Campbell JR, Oxlade O, Menzies D. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis. PLoS Med 2021;18:e1003712. [PMID: 34520463 DOI: 10.1371/journal.pmed.1003712] [Reference Citation Analysis]
3 Sumner T, Mendelsohn SC, Scriba TJ, Hatherill M, White RG. The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study. BMC Med 2021;19:252. [PMID: 34711213 DOI: 10.1186/s12916-021-02127-w] [Reference Citation Analysis]
4 Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE. Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration. Am J Epidemiol 2019;188:2078-85. [PMID: 31364692 DOI: 10.1093/aje/kwz172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 LaCourse SM, Wagner AD, Cranmer LM, Copeland A, Maleche-Obimbo E, Richardson BA, Matemo D, Kinuthia J, John-Stewart G. Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women. J Acquir Immune Defic Syndr 2019;82:41-5. [PMID: 31408031 DOI: 10.1097/QAI.0000000000002086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]